Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Captopril is a New Delhi metallo-β-lactamase-1 (NDM-1) inhibitor with an IC50 value of 7.9μM. It is composed of two units: a 3-mercapto-2-methylpropanoyl fragment and a proline residue. In this study, we synthesized simple amide derivatives of 3-mercapto-2-methylpropanoic acid, and then tested them as NDM-1 inhibitors in order to identify the pharmacophore for NDM-1 inhibition. We found that the lead compound 22 had an IC50 value of 1.0μM. Further structure simplification provided compounds 31 and 32, which had IC50 values of 15 and 10μM, respectively. As compound 32 is a clinically used antidote for metal poisoning, it has great potential to be repurposed to treat bacterial infections.

Original publication

DOI

10.1016/j.bmcl.2013.10.068

Type

Journal article

Journal

Bioorg Med Chem Lett

Publication Date

01/01/2014

Volume

24

Pages

386 - 389

Keywords

3-Mercapto-2-methylpropanoic acid, Captopril, Metalantidote, NDM-1 inhibitor, Captopril, Dose-Response Relationship, Drug, Enzyme Inhibitors, Molecular Structure, Structure-Activity Relationship, beta-Lactamase Inhibitors, beta-Lactamases